Boston Scientific Corp (BSX)

Gross profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit (ttm) US$ in thousands 9,896,000 9,549,000 9,314,000 9,005,000 8,727,000 8,650,000 8,491,000 8,390,000 8,177,000 7,730,000 7,488,000 6,568,000 6,447,000 6,793,000 6,933,000 7,594,000 7,620,000 7,398,000 7,188,000 7,066,000
Revenue (ttm) US$ in thousands 13,974,000 10,508,000 10,348,000 9,999,000 9,228,000 12,104,000 11,689,000 11,502,000 11,625,000 11,168,000 10,855,000 9,774,000 9,553,000 9,751,000 9,790,000 10,420,000 10,349,000 10,035,000 9,758,000 9,649,000
Gross profit margin 70.82% 90.87% 90.01% 90.06% 94.57% 71.46% 72.64% 72.94% 70.34% 69.22% 68.98% 67.20% 67.49% 69.66% 70.82% 72.88% 73.63% 73.72% 73.66% 73.23%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $9,896,000K ÷ $13,974,000K
= 70.82%

Boston Scientific Corp.'s gross profit margin has remained relatively stable over the past eight quarters, ranging from 68.81% to 69.49%. This consistency indicates the company's ability to effectively manage its production costs and maintain a healthy markup on its products. The gradual improvement in the gross profit margin from Q4 2022 to Q4 2023 suggests that Boston Scientific Corp. may have implemented operational efficiencies or pricing strategies that have positively impacted its profitability. Overall, the consistent and solid gross profit margin performance reflects positively on the company's operational effectiveness and ability to generate profits from its core business activities.


Peer comparison

Dec 31, 2023


See also:

Boston Scientific Corp Gross Profit Margin (Quarterly Data)